NCCR Guide 2013 - Schweizerischer Nationalfonds (SNF)
NCCR Guide 2013 - Schweizerischer Nationalfonds (SNF)
NCCR Guide 2013 - Schweizerischer Nationalfonds (SNF)
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Statistical Input – Output Data<br />
Funding source (CHF) Year 9 Year 10 Year 11 Year 12 Total %<br />
SNSF funding 3 600 000 2 000 000 1 500 000 800 000 7 900 000 21<br />
Self-funding from home<br />
institution 1 1 226 033 1 851 950 1 315 865 1 495 865 5 889 713 16<br />
Self-funding from ETH<br />
Zurich<br />
577 679 730 227 703 600 703 600 2 715 106 7<br />
Self-funding from project<br />
participants<br />
6 537 153 6 663 000 6 277 035 703 600 20 180 788 55<br />
Third-party funding 2 10 552 6 323 47 405 18 100 82 380 0<br />
Total 11 951 417 11 251 500 9 843 905 3 721 165 36 767 987 100<br />
Personnel 3<br />
1<br />
Personnel costs, equipment and consumables, not included infrastructure and basic equipment<br />
2<br />
Not included is CTI funding. Since the start of the <strong>NCCR</strong> 2 projects have been funded by CTI at a total amount<br />
of 2.1 million CHF (cf. third table).<br />
3<br />
Persons involved in the <strong>NCCR</strong> in the last reporting period (12 months)<br />
4<br />
Full-time equivalent, including <strong>NCCR</strong>-Director and persons in charge of knowledge and technology transfer,<br />
and education and training<br />
5<br />
Including leaders of the individual projects and other organisational units of the <strong>NCCR</strong><br />
6<br />
This table displays the major indicators in knowledge and technology transfer; other data is available as well (see text on<br />
“achievements”). The output data of <strong>NCCR</strong>s differ considerably according to disciplinary cultures.<br />
7<br />
Start-up companies that have been built up or were considerably supported by <strong>NCCR</strong>s.<br />
8<br />
Projects funded by the Commission for Technology and Innovation (CTI) that have been initiated by members of <strong>NCCR</strong>s<br />
and are thematically linked to <strong>NCCR</strong> projects.<br />
Evaluation and Monitoring by the Swiss National Science Foundation (SNSF)<br />
Members of the Review Panel<br />
Kléber André, Prof. (Chair)<br />
Eisenberg David, Prof.<br />
Fromm Katharina, Prof.<br />
Hall Mike, Prof.<br />
Michel Hartmut, Prof.<br />
Schmid Franz Xaver, Prof.<br />
Widmer Hans, Dr.<br />
Wright Ernest M., Prof.<br />
Wright Peter E., Prof.<br />
<strong>NCCR</strong> Office SNSF<br />
Christ Urs, Dr.<br />
Total of<br />
Persons<br />
Female % Male % CH Most Represented Nations Other<br />
Nations<br />
DE FR CN PL AT<br />
Management 3.0 4 2 25 6 75 3 2 1 0 0 0 2<br />
Master students 0 0 0 0 0 0 0 0 0 0 0 0<br />
Doctoral students 49 17 35 32 65 18 16 2 2 2 1 8<br />
Postdoctoral students 34 11 32 23 68 7 14 2 2 1 0 8<br />
Research associates 0 0 0 0 0 0 0 0 0 0 0 0<br />
Senior researchers 5 36 7 19 29 81 9 8 3 1 1 3 12<br />
Other staff 21 19 90 2 10 12 3 1 0 2 0 4<br />
Total 143.00 56 38 92 62 49 43 9 5 6 4 34<br />
Type of output 6<br />
Totals<br />
Publications > 609 Peer-reviewed | 9 Not peer-reviewed | 13 Anthology articles | 25 Books | 0 Reports 656<br />
Presentations at congresses > 1561<br />
Cooperations > 4 Programmes | 222 Research institutions | 41 Private sector | 0 Other 267<br />
Transfer activities > 24 Patents | 12 Licenses | 2 Start-ups 7 | 1 Prototypes/processes | 2 CTI-projects 8 41<br />
Swiss National Science Foundation, Berne, CH<br />
UCLA-DOE Institute for Genomics and Proteomics, US<br />
Swiss National Science Foundation, Berne, CH<br />
Swiss National Science Foundation, Berne, CH<br />
Max-Planck Institut für Biophysik, Frankfurt am Main, DE<br />
Laboratorium für Biochemie, Universität Bayreuth, DE<br />
Novartis Pharma AG, Basel, CH<br />
UCLA School of Medicine, Los Angeles, US<br />
Department of Molecular Biology, The Scripps Research<br />
Institute, La Jolla, US<br />
Schweiz. <strong>Nationalfonds</strong>, Wildhainweg 3, 3001 Bern<br />
phone: + 41 (0)31 308 23 50, fax: + 41 (0)31 305 29 71, uchrist@snf.ch<br />
• Laboratoire d’Enzymologie et<br />
Biochimie Structurales, Centre<br />
national de la Recherche<br />
Scientifique, Gif-sur-Yvette, FR<br />
• Lab. für Physikalische Chemie,<br />
ETH Zurich, Zurich, CH<br />
• Laboratory of Molecular Biology,<br />
National Institutes of Health,<br />
Bethesda, US<br />
• Laboratory of Protein<br />
Phosphorylation, Katholieke<br />
Universiteit Leuven, BE<br />
• M. D. Anderson Cancer Center,<br />
University of Texas, Houston, US<br />
• Max Planck Institute of Coal<br />
Research, Mühlheim, DE<br />
• Max von Pettenkofer Institute,<br />
Ludwig-Maximilians<br />
University of Munich, DE<br />
• Medizinische Biochemie und<br />
Molekularbiologie der Universität<br />
des Saarlands, Homburg, DE<br />
• National Chemical Laboratory<br />
(NCL), Central NMR Facility,<br />
Pune, IN<br />
• National Institute of<br />
Biotechnology, Madrid, ES<br />
• Russian Academy of Sciences,<br />
Moscow, RU<br />
• San Diego Joint Center for<br />
Structural Genomics, US<br />
• School of Biological Sciences,<br />
University of Auckland, NZ<br />
• School of Chemistry and<br />
Molecular Bioscience,<br />
The University of Queensland,<br />
Brisbane, AU<br />
• School of Medicine, Stanford<br />
University, Stanford, CA, US<br />
• Structural Biology – VUB,<br />
Free University of Brussels, BE<br />
• The Scripps Research Institute,<br />
La Jolla, US<br />
• UCL Cancer Institute,<br />
University College London, GB<br />
• Zentrum für Molekulare<br />
Biologie (ZMBH),<br />
Universität Heidelberg, DE<br />
Economy / Industry<br />
• Boehringer Ingelheim Pharma<br />
GmbH & Co. KG, Biberach, DE<br />
• Bruker AXS GmbH,<br />
Karlsruhe, DE<br />
• Cambridge Antibody Technology,<br />
Cambridge, GB<br />
• F. Hoffmann-La Roche Ltd.,<br />
Basel, CH<br />
• Molecular Dimensions Limited,<br />
Newmarket, GB<br />
• Molecular Partners AG,<br />
Zurich, CH<br />
• MorphoSys AG, Martinsried, DE<br />
• Roche Deutschland Holding<br />
GmbH, Penzberg, DE<br />
• Swissci AG, Neuheim, CH<br />
<strong>Guide</strong> <strong>2013</strong> | 19